0.32 (-%)
As of Nov 21, 2024
Source:
In8bio, Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell product candidates for solid and liquid tumors. Gamma-delta T cells are a specialized population of T cells that possess unique properties.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | ( 646 ) 600-6438 |
| Industry | manufacturing |
| CEO | William Ho |
| Website | www.in8bio.com |